MaxCyte Stock Options
| MXCT Stock | USD 2.02 0.13 6.05% |
MaxCyte's latest option contracts expiring on October 17th 2025 are carrying combined implied volatility of 1.86. The MaxCyte option chain provides detailed quote and price information for the current MaxCyte option contracts. It shows all of MaxCyte's listed puts, calls, expiration dates, strike prices, and other pricing information.
In The Money vs. Out of Money Option Contracts on MaxCyte
Analyzing MaxCyte's in-the-money options over time can help investors to take a profitable long position in MaxCyte regardless of its overall volatility. This is especially true when MaxCyte's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money MaxCyte's options could be used as guardians of the underlying stock as they move almost dollar for dollar with MaxCyte's stock while costing only a fraction of its price.
MaxCyte Current Options Market Mood
MaxCyte's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps MaxCyte Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most MaxCyte's options investors are not very successful. MaxCyte's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current MaxCyte contract
Base on the Rule 16, the options market is currently suggesting that MaxCyte will have an average daily up or down price movement of about 0.12% per day over the life of the 2025-10-17 option contract. With MaxCyte trading at USD 2.02, that is roughly USD 0.002348. If you think that the market is fully incorporating MaxCyte's daily price movement you should consider buying MaxCyte options at the current volatility level of 1.86%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing MaxCyte options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" MaxCyte calls. Remember, the seller must deliver MaxCyte stock to the call owner when a call is exercised.
MaxCyte Option Chain
When MaxCyte's strike price is surpassing the current stock price, the option contract against MaxCyte stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
MaxCyte's option chain is a display of a range of information that helps investors for ways to trade options on MaxCyte. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for MaxCyte. It also shows strike prices and maturity days for a MaxCyte against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | MXCT251017C00007500 | 0 | 7.5 | 0.0 - 0.75 | 0.75 | |
Call | MXCT251017C00005000 | 42 | 5.0 | 0.0 - 0.75 | 0.1 | Out |
Call | MXCT251017C00002500 | 15 | 2.5 | 0.0 - 2.4 | 0.24 | Out |
Put | MXCT251017P00007500 | 0 | 7.5 | 4.2 - 5.7 | 4.2 | In |
Put | MXCT251017P00005000 | 0 | 5.0 | 2.7 - 3.1 | 2.7 | In |
Put | MXCT251017P00002500 | 0 | 2.5 | 0.0 - 0.85 | 0.85 | In |
MaxCyte Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
MaxCyte Total Stockholder Equity
Total Stockholder Equity |
|
MaxCyte Corporate Management
| James Brady | Senior Support | Profile | |
| Stark Thompson | Consultant | Profile | |
| Jill Mayer | Senior Resources | Profile | |
| Cenk Sumen | Chief Officer | Profile | |
| Douglas Doerfler | President, Founder | Profile | |
| Jay Gelfman | Senior Operations | Profile |
Additional Tools for MaxCyte Stock Analysis
When running MaxCyte's price analysis, check to measure MaxCyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MaxCyte is operating at the current time. Most of MaxCyte's value examination focuses on studying past and present price action to predict the probability of MaxCyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MaxCyte's price. Additionally, you may evaluate how the addition of MaxCyte to your portfolios can decrease your overall portfolio volatility.